<DOC>
	<DOCNO>NCT00745043</DOCNO>
	<brief_summary>Smoking cause smoke related lung disease ( COPD ) ischaemic heart disease . These common condition many patient disease . Beta-blocker drug extensively use treatment angina , high blood pressure heart attack decrease symptom prolong life . Beta-agonists use COPD decrease breathlessness improve exercise tolerance . It use think beta-blockers use COPD patient may make breathlessness bad , establish use safely . Beta-blocker drug beta-agonists 'opposite ' effect body investigator know work together would cancel . The investigator also know different type beta-blockers available good COPD patient . This study investigate happen airways people take drug .</brief_summary>
	<brief_title>Beta-Blocker Chronic Obstructive Pulmonary Disease ( COPD ) Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Clinical diagnosis COPD &gt; 40 year age &gt; 15 pack year smoke history Contraindication betablocker use Severe COPD FEV1 &lt; 30 % 1 L Not responsive methacholine</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>Betablockers</keyword>
	<keyword>bronchodilator</keyword>
	<keyword>exercise capacity</keyword>
	<keyword>methacholine challenge</keyword>
</DOC>